Study findings at 12 months showed prolonged significant improvements in objective urinary parameters.
Solifenacin-treated patients experienced less dry mouth than those taking oxybutynin immediate release.
Researchers have reported encouraging results from a small study examining intravesical instillation of a botulinum toxin/dimethyl sulfoxide (DMSO) solution as a treatment for refractory idiopathic overactive bladder (OAB).
Watson Pharmaceuticals, Corona, Calif., has received approval for Gelnique (oxybutynin chloride) Gel 10%, the first and only topical gel for the treatment of overactive bladder (OAB).
The procedure is ideal in this population because it is minimally invasive and highly efficacious
Increased bladder sensation and detrusor overactivity are the most frequent urodynamic findings of overactive bladder (OAB) in women with diabetes, researchers in Taiwan reported in Neurourology and Urodynamics (2009; published online ahead of print).